269 related articles for article (PubMed ID: 9055644)
1. Effect of nalidixic acid on recombination and DNA repair of Escherichia coli K-12 strains.
Inan S; Kalaycioglu A
Indian J Exp Biol; 1996 Oct; 34(10):949-53. PubMed ID: 9055644
[TBL] [Abstract][Full Text] [Related]
2. [Interactions of subunits of DNA gyrase].
Bogdanova ES; Mirkin SM; Shmerling ZhG
Mol Biol (Mosk); 1982; 16(5):1019-25. PubMed ID: 6292700
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of DNA gyrase-mediated illegitimate recombination: characterization of Escherichia coli gyrA mutations that confer hyper-recombination phenotype.
Ashizawa Y; Yokochi T; Ogata Y; Shobuike Y; Kato J; Ikeda H
J Mol Biol; 1999 Jun; 289(3):447-58. PubMed ID: 10356321
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of and resistance to ciprofloxacin.
Hooper DC; Wolfson JS; Ng EY; Swartz MN
Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
[TBL] [Abstract][Full Text] [Related]
5. 4-quinolones and the SOS response.
Lewin CS; Howard BM; Ratcliffe NT; Smith JT
J Med Microbiol; 1989 Jun; 29(2):139-44. PubMed ID: 2659796
[TBL] [Abstract][Full Text] [Related]
6. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
[TBL] [Abstract][Full Text] [Related]
7. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
8. [Temperature-sensitive mutant Escherichia coli for the B-subunit of DNA-gyrase. The effect on replication and transcription].
Mirkin SM; Shmerling ZhG
Genetika; 1983 Mar; 19(3):425-34. PubMed ID: 6303902
[TBL] [Abstract][Full Text] [Related]
9. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Howard BM; Pinney RJ; Smith JT
Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
[TBL] [Abstract][Full Text] [Related]
10. [Dependence of the viability and mutability of Escherichia coli K-12 cells on the balance of DNA and protein syntheses. II. The effect of disturbance in the balance of DNA and protein syntheses on the cellular mutability and viability of rec+ and rec- strains treated with nalidixic acid].
Fradkin GE; Torosian MV; Shishkova OV; Aĭzenberg OA; Rabinkova EV
Genetika; 1979 Dec; 15(12):2148-55. PubMed ID: 389738
[TBL] [Abstract][Full Text] [Related]
11. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.
Herrera G; Aleixandra V; Urios A; Blanco M
FEMS Microbiol Lett; 1993 Jan; 106(2):187-91. PubMed ID: 8384139
[TBL] [Abstract][Full Text] [Related]
12. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
Brino L; Mousli M; Oudet P; Weiss E
Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
[TBL] [Abstract][Full Text] [Related]
13. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
Eraç B; Gill A; Amyes SG; Gülay Z
Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of onset of quinolone-resistant mutants in E. coli strains].
Matinca D; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):169-70. PubMed ID: 15341335
[No Abstract] [Full Text] [Related]
15. Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones.
Marchetto R; Nicolás E; Castillo N; Bacardit J; Navia M; Vila J; Giralt E
J Pept Sci; 2001 Jan; 7(1):27-40. PubMed ID: 11245203
[TBL] [Abstract][Full Text] [Related]
16. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
[TBL] [Abstract][Full Text] [Related]
17. Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
Brino L; Mousli M; Oudet P; Weiss E
Plasmid; 1997; 38(3):188-201. PubMed ID: 9435021
[TBL] [Abstract][Full Text] [Related]
18. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
[TBL] [Abstract][Full Text] [Related]
19. Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase.
del Castillo FJ; del Castillo I; Moreno F
J Bacteriol; 2001 Mar; 183(6):2137-40. PubMed ID: 11222617
[TBL] [Abstract][Full Text] [Related]
20. Mutations affecting gyrase in Haemophilus influenzae.
Setlow JK; Cabrera-Juárez E; Albritton WL; Spikes D; Mutschler A
J Bacteriol; 1985 Nov; 164(2):525-34. PubMed ID: 2997115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
